FY 2027 ICD-10-CM Code Update
Key Diagnosis Code Changes Every Healthcare Organization Should Prepare For
An Averon Group Healthcare Consulting Brief
The Centers for Medicare & Medicaid Services (CMS) has released the Fiscal Year (FY) 2027 ICD-10-CM diagnosis code update, effective October 1, 2026. The annual update introduces 238 new diagnosis codes, 4 revised code descriptions, and 21 deleted codes, reflecting continued efforts to improve clinical specificity, documentation accuracy, quality reporting, and reimbursement.
For healthcare organizations, these changes extend well beyond coding. They impact provider documentation, electronic health record (EHR) configuration, medical necessity validation, payer edits, clinical decision support, quality reporting, and revenue cycle performance. Organizations should begin implementation planning well in advance of the October 1 effective date to ensure compliance and minimize claim disruptions.
Major FY 2027 ICD-10-CM Changes
Neoplasm and Hematology
The FY 2027 update expands the reporting options for secondary malignant neoplasms by increasing the specificity of metastatic cancer coding. Existing categories for secondary malignant neoplasms of the respiratory, digestive, and other anatomical sites have been expanded with additional diagnosis codes that more precisely identify metastatic locations.
Additional refinement has also been made within Diseases of the Blood and Blood-Forming Organs. Category D69.1 (Qualitative Platelet Defects) has been reorganized to distinguish inherited platelet disorders from other qualitative platelet abnormalities.
Two new diagnosis codes have been introduced:
D69.11 – Glanzmann thrombasthenia
D69.19 – Other qualitative platelet defects
This change improves the identification of inherited platelet disorders including Glanzmann disease, Bernard-Soulier syndrome, grey platelet syndrome, and other thrombocytopathies.
An important documentation change also affects breast carcinoma in situ. Beginning October 1, providers should no longer report a malignant breast neoplasm diagnosis together with a carcinoma in situ diagnosis when both describe the same disease process.
New Postprocedural Hypoglycemia Codes
Three new diagnosis codes have been established to identify hypoglycemia occurring after surgical procedures:
E89.83 – Postprocedural hypoglycemia following a procedure
E89.830 – Post-bariatric hypoglycemia
E89.838 – Other postprocedural hypoglycemia
These additions improve reporting accuracy for postoperative metabolic complications, particularly following bariatric surgery.
Cardiovascular Updates
Cardiology receives several important enhancements designed to improve clinical specificity.
The existing diagnosis:
I42.0 – Dilated cardiomyopathy
has been expanded into distinct reportable diagnoses that differentiate:
Unspecified dilated cardiomyopathy
Familial/genetic dilated cardiomyopathy
Other dilated cardiomyopathy
This increased specificity supports improved clinical documentation, research, quality reporting, and reimbursement.
Otolaryngology (ENT)
A new diagnosis category has been introduced for odontogenic sinusitis, recognizing sinus disease originating from dental pathology.
New subcategory:
J34.83- Odontogenic sinusitis
Additional characters identify the affected sinus, including:
Maxillary
Ethmoid
Frontal
Sphenoid
ENT specialists should review documentation templates to ensure anatomical site specificity is consistently documented.
Digestive System Updates
Several notable gastrointestinal changes become effective in FY 2027.
Highlights include:
New code K31.B for hypertrophic pyloric stenosis in childhood.
New K6A category for diseases of the pelvis not elsewhere classified.
New diagnosis K74.0A identifying moderate hepatic fibrosis (Stage F2).
These additions improve staging accuracy and support more precise clinical reporting.
Dermatology
The FY 2027 update introduces one new diagnosis and revises several existing skin infection codes.
New diagnosis:
L02.237 – Carbuncle of flank
Revised diagnoses clarify anatomical locations involving the back while excluding the buttock and flank for:
Carbuncle
Cellulitis
Acute lymphangitis
These revisions improve anatomical precision and coding consistency.
Musculoskeletal System
Orthopedic and sports medicine providers will see several important additions.
Plantar Fasciitis
A new diagnosis category:
M67.A- Plantar fasciitis
has been added along with diagnosis codes identifying plantar fascial fibromatosis.
Osteomyelitis
The M86.8X code family has been expanded to include laterality and anatomical specificity using seventh-character extensions.
VEXAS Syndrome
FY 2027 introduces a new diagnosis code recognizing VEXAS syndrome, a recently identified adult-onset autoinflammatory disease characterized by severe systemic inflammation and immune dysregulation.
Obstetrics and Gynecology
Women's health experiences one of the largest expansions in the FY 2027 update.
Key additions include:
New N99.86 category for intraoperative and postprocedural breast complications.
Fifty-six new ectopic pregnancy diagnosis codes.
New O31.4 category identifying continuing pregnancy following vanishing twin syndrome.
These additions significantly improve documentation specificity throughout obstetrical care.
Congenital Disorders
Several new congenital diagnosis codes have been added for hereditary syndromes including:
Loeys-Dietz syndrome
Lynch syndrome
Li-Fraumeni syndrome
These additions enhance reporting of hereditary cancer syndromes and connective tissue disorders.
Laboratory Findings
A new laboratory diagnosis has been introduced:
R78.72 – Abnormal gadolinium level in blood
This code supports documentation of abnormal gadolinium exposure and monitoring.
Injury Coding
The existing diagnosis for sternoclavicular sprain has been deleted, requiring providers and coders to transition to replacement diagnosis options where appropriate.
Toxic Effects
Additional diagnosis codes have been created for toxic effects involving alkenes and related chemical exposures, expanding occupational and environmental health reporting.
Social Determinants of Health and Gender-Specific Reporting
FY 2027 continues CMS's effort to improve demographic and social reporting.
Updates include:
Refinement of existing Z-code descriptions
Expansion of selected broad categories into more specific reportable diagnoses
Improved sensitivity and specificity when documenting patient sex and gender-related clinical information
These changes support health equity initiatives, quality reporting, and more accurate patient representation.
Revenue Cycle Considerations
Healthcare organizations should prepare for implementation by:
Updating diagnosis dictionaries within the EHR.
Installing FY 2027 ICD-10-CM code tables.
Revising medical necessity edits.
Updating payer-specific diagnosis mappings.
Reviewing LCD and NCD diagnosis requirements.
Training providers, coders, CDI specialists, and revenue cycle staff.
Performing pre-implementation claim testing.
Monitoring denials closely during the first 60–90 days following implementation.
Averon Group Recommendations
Successful implementation requires a coordinated organizational approach involving clinical operations, coding, compliance, information technology, and revenue cycle leadership.
Averon Group recommends establishing a formal ICD-10 implementation project that includes:
Executive sponsorship
Cross-functional implementation teams
Provider education
Documentation improvement initiatives
Coding quality audits
Revenue cycle monitoring
Post-implementation denial analysis
Ongoing compliance reviews
Organizations that proactively prepare for the FY 2027 ICD-10-CM update will reduce coding errors, improve documentation quality, strengthen reimbursement accuracy, and minimize operational disruption during implementation.
